OBJECTIVE-Type 2 diabetes is characterized by diminished pancreatic ␤-cell mass and function. Insulin signaling within the ␤-cells has been shown to play a critical role in maintaining the essential function of the ␤-cells. Under basal conditions, enhanced insulin-PI3K signaling via deletion of phosphatase with tensin homology (PTEN), a negative regulator of this pathway, leads to increased ␤-cell mass and function. In this study, we investigated the effects of prolonged ␤-cell-specific PTEN deletion in models of type 2 diabetes.
T he quintessential defects in type 2 diabetes are the development of peripheral insulin resistance and ␤-cell dysfunction (1) (2) (3) . In fact, the loss of insulin secretion in ␤-cells in response to glucose occurs before the emergence of insulin resistance and hyperglycemia (4 -6) . Once insulin resistance develops, hyperglycemia, high-circulating free fatty acids, and inflammatory cytokines further abrogate glucose-stimulated insulin secretion (2, (7) (8) (9) . It is becoming increasingly clear that insulin/insulin-like growth factor 1 (IGF-1) signaling plays an important role in the maintenance of ␤-cell function under both basal and diabetic conditions. Mice with ␤-cell-specific deletion of IGF-1 receptor exhibit a defect in glucose-stimulated insulin secretion (10, 11) , whereas insulin receptor deletion in ␤-cells results in both attenuated insulin secretion in response to glucose and reduced ␤-cell mass with aging (12, 13) . Thus, ␤-cells are not only an essential source of the hormone insulin, but are also a critical target of insulin action in the maintenance of ␤-cell function.
Phosphoinositide 3-kinase (PI3K) signaling cascade is one of the major intracellular signaling pathways through which insulin and IGF-1 mediate their effects (14) . Phosphatase with tensin homology (PTEN) is a dual-specific phosphatase and a potent negative regulator of this pathway by its ability to dephosphorylate phosphatidylinosotol-3,4,5-triphosphate (PIP3) to phosphatidylinosotol-4,5-bisphosphate (PIP2), thereby effectively removing the critical secondary messenger of this signaling cascade (15, 16) . Although PTEN was first discovered as a tumor suppressor, recent studies have highlighted the important physiologic role of PTEN in metabolism (16 -18) . Tissuetargeted deletion of PTEN in liver, fat, or muscle lead to improved insulin sensitivity in these insulin-responsive tissues and protects mice from HFD-induced diabetes (19 -22) . Additionally, we and others have reported that mice with PTEN deletion in pancreatic ␤-cells show increased ␤-cell mass because of both increased proliferation and reduced apoptosis without compromising ␤-cell function under the basal condition (23, 24) .
PTEN has been shown to be upregulated in models of insulin resistance, including a genetic model of combined ablation of insulin/IGF-1 signaling in ␤-cells (25) (26) (27) . Furthermore, in vitro overexpression of PTEN in pancreatic ␤-cell lines showed impaired insulin secretion in response to ambient glucose (28) . However, the regulation of PTEN expression in ␤-cells in models of type 2 diabetes in vivo was unknown. We show here that PTEN expression was increased in islets of both high-fat diet (HFD)-fed and db/db mice, which was accompanied by attenuation in PI3K signaling, suggesting the potential causal role of PTEN in the pathogenesis of ␤-cell dysfunction in type 2 diabetes. In this report, we investigated the essential role of PTEN in ␤-cells in the context of type 2 diabetes models. We used the rat insulin promoter (RIP) to drive deletion of PTEN in the Cre-loxP system (RIPcre ϩ Pten fl/fl ). RIPcre ϩ Pten fl/fl mice were protected from HFDinduced type 2 diabetes because of their increased islet mass and proliferation with intact ␤-cell function. ␤-Cells from RIPcre ϩ Pten fl/fl mice were protected against HFDinduced ␤-cell dysfunction both in vitro and in vivo, which can be attributed to the constitutively active PI3K signaling in their islets. Furthermore, RIPcre ϩ Pten fl/fl mice in the db/db background still remained euglycemic, despite being severely insulin resistant. Interestingly, their ␤-cell mass was not significantly different from db/db littermates. However, their ␤-cell function and islet PI3K signaling remained intact. Together, our data highlight the critical role of ␤-cell PTEN in the development of ␤-cell dysfunction in type 2 diabetes and support PTEN as a potential therapeutic target for ␤-cell growth and the preservation of its function. Only male mice were used for experiments and only littermates were used as controls. Genotypes for Cre and Pten gene were determined with PCR using ear clip DNA as described previously (19, 23) . All mice were maintained on a mixed 129J-C57BL/6 background and housed in a pathogen-free facility on a 12-h light-dark cycle and fed ad libitum with standard irradiated rodent chow (5% fat; Harlan Tecklad, Indianapolis, IN) in accordance with the Ontario Cancer Institute Animal Care Facility protocol, with no restrictions on the animals' activities. High-fat diet feeding. HFD (Dyets lard Surmwit mouse diet DYET# 182084; Fyets Inc., Bethlehem, PA) for RIPcre ϩ Pten fl/fl and RIPcre ϩ Pten ϩ/ϩ mice was started for mice at 2 months of age and continued for 7 months. Metabolic studies. All overnight fasts were carried out between 5:00 P.M. and 10:00 A.M. All blood glucose, glucose tolerance tests, insulin tolerance tests, and glucose-stimulated insulin secretion tests were performed on overnightfasted animals as previously described (23) . Islet perifusion assay. Detailed perifusion protocol was described in a previous publication (29) . In brief, 60 islets were placed in a perifusion chamber at 37°C with a capacity of 1.3 ml, and perifused with Kreb-Ringer bicarbonate buffer at 1 ml/min. Islets were equilibrated with Kreb-Ringer bicarbonate HEPES buffer (2.8 mmol/l glucose) for 30 min. They were then stimulated with 2.8 mmol/l glucose for 10 min, followed by a 40-min incubation with 16.7 mmol/l glucose. Fractional insulin content was determined with radioimmunoassay kit (Linco Research, St. Louis, MO). At the end of each perifusion, islets were collected and lysed with acid ethanol for assessment of insulin content. First phase secretion was 10 to 25 min, and second phase secretion was 25 to 50 min. Results were presented as insulin secreted normalized to 60 islets and to total insulin content. Immunohistochemistry and immunofluorescence. Pancreas was fixed in 4% paraformaldehyde in 0.1M PBS (pH 7.4) as previously described (25) . For immunohistochemical and immunofluorescent staining antibodies against PTEN (NeoMarker, Fremont, CA), Akt (Cell Signaling Technology, Beverly, MA), p-Akt (Ser473) (Cell Signaling Technology, Beverly, MA), insulin (DAKO), glucagon (NovoCastra Laboratories), laminin (Sigma), ␤-catenin (BD Transduction Laboratories), GLUT2 (Chemicon, Temecula, CA), PDX-1 (Chemicon, Temecula, CA), and Ki67 (DAKO) were used. Total islet area and total pancreas area were determined on insulin immunohistochemically stained sections with Image-Pro Plus software (Media Cybernetics, Silver Spring, MD) and expressed as total islet area per total pancreas area.
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Proportions of different islet sizes were measured on H&E-stained pancreas sections: small (Ͻ10 cells), medium (10 -200 cells) , and large (Ͼ200 cells). ␤-Cell size was determined with insulin/DAPI costained pancreas sections. Insulin-positive area was determined with Image-Pro Plus software (Media Cybernetics, Silver Spring, MD) and divided by the number of DAPI-positive nuclei within the insulin-stained areas. Western blotting. Islets and hypothalami were isolated and protein lysates were obtained as previously described (23 (30) . PCR was monitored in real time using the ABI Prism 7900HT Real-Time PCR system (Applied Biosysterm). Experiments were performed in triplicate for each sample. Primer sequences for Mdm2, Bax, and p21 are available upon request. Statistics. Data are presented as mean Ϯ SEM and were analyzed by one-sample t test, independent-sample t test, and one-way ANOVA with the post hoc Tukey least significant difference test, when appropriate. All data were analyzed using the statistical software package SPSS (version 16.0) for Macintosh.
RESULTS
Increased PTEN expression with attenuated PI3K signaling in islets of HFD-fed and db/db mice. PTEN transcript and protein levels were measured in islets of mice with type 2 diabetes. In both HFD-induced and db/db mice, PTEN transcripts in islets were significantly increased as accessed by quantitative real-time PCR (Fig.  1A) . PTEN protein expression was also increased as demonstrated by immunohistochemistry of pancreatic sections and Western blotting of isolated islet lysates ( Fig.  1B and C) . The increase in islet PTEN expression in both of these type 2 diabetes models was accompanied by attenuated PI3K signaling, as demonstrated by the reduction of p-Akt, p-mTOR, and p-FoxO-1 expression (Fig. 1C) . RIPcre ؉ Pten fl/fl mice were protected against HFDinduced diabetes. We have previously shown that RIPcre ϩ Pten fl/fl mice exhibit an increase in ␤-cell mass and function under basal conditions (23) . To investigate whether these positive attributes of PTEN deletion in pancreatic ␤-cells conferred protection against type 2 diabetes, we fed these mice a prolonged HFD for 7 months. Efficient PTEN deletion in ␤-cells, along with partial deletion in the hypothalamus, persisted in the RIPcre ϩ Pten fl/fl mice on prolonged HFD ( Fig. 2A and B) . Despite their increased weight gain upon HFD feeding, RIPcre ϩ Pten fl/fl mice remained remarkably euglycemic throughout the duration of prolonged HFD, in contrast to the gradual increase in blood glucose levels in control littermates ( Fig. 3A and B) . They also exhibited improved glucose tolerance (Fig. 3C ). The attenuation of insulin secretion in response to glucose is a characteristic ␤-cell defect in type 2 diabetes (1-3). Indeed, this attenuation was observed in both the first and second phases of insulin secretion after in vivo glucose challenge in wild-type mice after a prolonged HFD. In contrast, insulin secretion in response to glucose was preserved in RIPcre ϩ Pten fl/fl mice ( Fig. 3D) .
Increased ␤-cell mass and ␤-cell size in islets of HFD-fed RIPcre ؉ Pten fl/fl mice. During HFD-induced diabetes, development of peripheral insulin resistance leads to a compensatory increase in ␤-cell mass to meet the increasing demands for insulin. This compensatory proliferation was observed in RIPcre ϩ Pten ϩ/ϩ islets on HFD ( Fig. 4A and B) . RIPcre ϩ Pten fl/fl islets showed an already increased ␤-cell mass under chow-fed conditions, and we observed no further increase in ␤-cell mass in the mice on HFD. The increased ␤-cell mass was due to both an increase in proliferation and ␤-cell size in RIPcre However, after HFD feeding, RIPcre ϩ Pten fl/fl mice maintained robust insulin secretion in response to glucose in contrast to islets of HFD-fed RIPcre ϩ Pten ϩ/ϩ mice, which showed attenuation in both phases of insulin secretion ( Fig. 4I and J) . These data suggest that diabetes protection in HFD-fed RIPcre ϩ Pten fl/fl mice are likely due to both preserved ␤-cell function and mass. Maintained high PI3K signaling in RIPcre ؉ Pten fl/fl islets after prolonged HFD. To determine the mechanisms underlying the enhanced ␤-cell growth and maintained function after HFD feeding in islets of RIPcre ϩ Pten fl/fl mice, we assessed for alterations in the PI3K signaling pathway. HFD has been shown to attenuate phosphorylation of Akt in ␤-cells (7). However this decline was not observed in PTEN-deficient islets, which indicates persistent activation of the PI3K pathway even after prolonged exposure to HFD (Fig. 5A and B) . FoxO-1 and mTOR, both downstream effectors of PI3K signaling, showed increased phosphorylation in HFD-fed RIPcre ϩ Pten fl/fl islets (Fig. 5B) . The increased p-mTOR was in keeping with the increased ␤-cell size in RIPcre ϩ Pten fl/fl mice ( Fig. 4E and F) . The expression of GLUT-2, a marker of ␤-cell differentiation and a rate-limiting component in glucose sensing, has also been shown to decline with the progression of type 2 diabetes (31, 32) . GLUT2 remained high in HFD-fed RIPcre ϩ Pten fl/fl islets to a similar degree as the islets of chow-fed RIPcre ϩ Pten ϩ/ϩ mice, in contrast with the decline of GLUT2 in islets of HFD-fed RIPcre ϩ Pten ϩ/ϩ mice ( Fig. 5A and B) . Furthermore, PDX-1, a downstream transcriptional target of insulin signaling important in ␤-cell differentiation and growth (33) , was also increased in RIPcre ϩ Pten fl/fl islets, which may also contribute to the preserved ␤-cell mass and function in HFD-fed RIPcre ϩ Pten fl/fl mice ( Fig. 5A and B) Fig. 6A and D) . However, despite severe insulin resistance in RIPcre ϩ Pten fl/fl Lepr db/db mice, they continued to remain remarkably euglycemic and showed normal glucose tolerance (Fig. 6B and C) Lepr db/db islets and did not show a further increase in ␤-cell mass compared with db/db controls ( Fig. 7B and C) .
Islets of RIPcre
ϩ Pten fl/fl Lepr db/db mice showed no signs of disorganized architecture (Fig. 7A) . (Fig. 6F and G) . Fig. 7A and D) . Phosphorylation of mTOR and FoxO-1 also remained high in RIPcre ϩ Pten fl/fl Lepr db/db islets, consistent with constitutively active PI3K cascade (Fig.  7D ). In keeping with its normal insulin secretion in response to glucose, GLUT2 was highly expressed in islets of RIPcre ϩ Pten fl/fl Lepr db/db mice in contrast to the nearcomplete loss of GLUT2 expression in islets of Lepr db/db mice ( Fig. 7A and D Lepr db/db islets, intact islet integrity was observed even in the 9-month-old aged mice fed either HFD or on db/db background. Intact laminin staining in the basement membrane as well as localization of ␤-catenin to the plasma membrane both demonstrated absence of deregulated growth (Fig. 8A) . Furthermore, induction of DNA damage with gamma irradiation showed a similar degree of DNArepair and apoptosis response in both RIPcre ϩ Pten ϩ/ϩ and RIPcre ϩ Pten fl/fl islets, including phosphorylation of p53 and cleavage of MDM2 (Fig. 8C) . The transcript levels of p53 target genes, including Bax, Mdm2, and p21 also showed similar changes in response to gamma irradiation between RIPcre ϩ Pten ϩ/ϩ and RIPcre ϩ Pten fl/fl islets (Fig.  8B) . Interestingly RIPcre ϩ Pten fl/fl islets exhibited significantly reduced expression of proapoptotic gene Bax under basal condition, which is consistent with their constitutively active PI3K signaling (Fig. 8B) . Thus, PTEN deletion in ␤-cells protects against ␤-cell dysfunction in both HFD and db/db models of type 2 diabetes with no finding suggestive of deregulated growth. Furthermore, PTENdeleted ␤-cells still maintained intact response to DNAdamaging stimuli, which further suggests that they are not more prone to tumor formation.
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DISCUSSION
In pre-diabetic individuals, insulin resistance in the classic metabolic tissues including the liver, muscle, and fat is present; however, glucose homeostasis can be maintained as long as pancreatic ␤-cells are able to increase insulin production to compensate for increased insulin demands (7, 34, 35) . Accumulating evidence shows that a defect in insulin-PI3K signaling in pancreatic ␤-cells may contribute to the development of ␤-cell dysfunction, leading to the onset of type 2 diabetes. Indeed, mice with genetic ablation of insulin/IGF-1 receptors specifically in the ␤-cells demonstrate reduced ␤-cell function (10, 12, 13) . Therefore, a new paradigm of type 2 diabetes pathogenesis suggests that diminished insulin responsiveness specifically in the pancreatic ␤-cells plays a central role in disease development.
Interestingly, PTEN, a critical negative regulator of the PI3K signaling pathway, has been shown to be upregulated in ␤-cells that have complete absence of insulin/IGF-1 signaling (25), leading to a hypothesis that PTEN may play a causal role in the pathogenesis of ␤-cell dysfunction. Here we have shown that when type 2 diabetes was induced, either by HFD or global leptin signaling deficiency, increased PTEN expression was observed in islets along with diminished PI3K signaling, suggesting that ␤-cell PTEN may indeed play a critical role in the development of type 2 diabetes. We and others have already shown that tissue-specific increase in PI3K signaling in pancreatic ␤-cells resulting from deletion of PTEN leads to increased ␤-cell mass and function under basal conditions (23, 24) . However, the biologic outcome from continued deletion of PTEN in ␤-cells under metabolically stressed conditions was elusive. In this report, we show that after prolonged HFD, RIPcre ϩ Pten fl/fl mice continued to exhibit increased islet mass and were protected against the loss of glucose-stimulation insulin secretion. The enhanced ␤-cell function was demonstrated not only in vivo, but also in vitro, which supports the direct effect of PTEN in ␤-cells. Lepr db/db islets remained responsive to glucose-stimulated insulin secretion. This is likely attributed by the PI3K signaling which remained activated in these islets. As such GLUT-2 and PDX-1, which are important in glucose sensing and cell differentiation, are maintained. These data illustrate the importance of the negative regulation that PTEN exerts on ␤-cells, whereupon PTEN deletion leads to enhanced PI3K signaling and protection against ␤-cell dysfunction that occurs in type 2 diabetes.
Given the well known tumorigenic effects of PTEN deletion in some tissues, we assessed for evidence of deregulated growth (16 -18) . PTEN deficient islets showed intact architecture and demonstrated intact DNA repair response to gamma irradiation as wild-type counterparts. Furthermore, previously we have shown that PTEN deletion in combination with the activation of the cMyc oncogene is still not able to lead to tumor formation (36) . However, more extensive analysis and longitudinal observation are required to conclusively demonstrate the full impact of PTEN deletion in pancreatic ␤-cells on tumorigenesis. It is worth noting that PTEN-deleted ␤-cells behave differently than ␤-cells that express constitutively active Akt. Although the RIP-Akt transgenic mice exhibit increased islet mass, these mice have compromised ␤-cell function (37, 38) . PTEN-deficient ␤-cells, in contrast, do not show loss of function even after a prolonged exposure to HFD, despite the continued proliferation and PI3K signaling within these cells. This important distinction between PTEN-deleted and Akt-overexpressing ␤-cells illustrates the fundamental difference between removing a physiologic brake, which would allow for PI3K signaling to return to physiologic levels, whereas forced expression of Akt may lead to supraphysiologic levels of PI3K signaling that can lead to cell proliferation and dedifferentiation. Further investigations to delineate other important genes or pathways that distinguish between these two modes of enhancing PI3K signaling may unveil clinically safe therapeutic targets for ␤-cells.
In summary, our findings show that PTEN plays a critical role in the pathogenesis of ␤-cell dysfunction in type 2 diabetes and highlight the tissue-specific role of PTEN in attenuating PI3K signaling in ␤-cells. Our results show that PTEN deletion in ␤-cells leads to an increase in ␤-cell mass and function as a result of restoring PI3K signaling to a physiologic level in diabetic condition. Indeed, PTEN deletion leads to complete protection against ␤-cell defects even in the face of severe insulin resistance, providing genetic evidence of the critical negative regulation that PTEN exerts in impeding ␤-cell function and growth that occurs in type 2 diabetes. Our results highlight opportunities for therapeutic targeting of PTEN in ␤-cells for treatment or prevention of type 2 diabetes. 
